The global platelet rich plasma market size was USD 723.97 million in 2023, calculated at USD 834.74 million in 2024 and is projected to surpass around USD 3,466.11 million by 2034, expanding at a CAGR of 15.3% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Covid-19: Platelet Rich Plasma Industry Impact
5.2. Platelet Rich Plasma Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Platelet Rich Plasma Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Platelet Rich Plasma Market Players to deal with Covid-19 Pandemic Scenario
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Intensifying elderly population and mounting pervasiveness of orthopedic situtaions
6.1.1.2. Growing applications of platelet-rich plasma products in hair transplant and other cosmetic applications
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Platelet Rich Plasma Market Revenue by Market Players
7.1.1.2. Platelet Rich Plasma Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users
8.1. Platelet Rich Plasma Market, by Component, 2024-2034
8.1.1. Leukocyte Rich PRP
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Pure PRP
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Leukocyte Rich Fibrin
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. Platelet Rich Plasma Market, by Application, 2024-2034
9.1.1. Allogeneic PRP
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Autologous PRP
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Homologous PRP
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. Platelet Rich Plasma Market, by End-user, 2024-2034
10.1.1. Cosmetic Surgery & Dermatology
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Orthopedic Surgery
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. General Surgery
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Ophthalmic Surgery
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Neurosurgery
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue Forecast by Product Type(2021-2034)
11.1.2. Market Revenue Forecast by Application (2021-2034)
11.1.3. Market Revenue Forecast by End-user (2021-2034)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2021-2034)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2021-2034)
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type(2021-2034)
11.2.2. Market Revenue Forecast by Application (2021-2034)
11.2.3. Market Revenue Forecast by End-user (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2021-2034)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2021-2034)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type(2021-2034)
11.3.2. Market Revenue Forecast by Application (2021-2034)
11.3.3. Market Revenue Forecast by End-user (2021-2034)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2021-2034)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2021-2034)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type(2021-2034)
11.4.2. Market Revenue Forecast by Application (2021-2034)
11.4.3. Market Revenue Forecast by End-user (2021-2034)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2021-2034)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2021-2034)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type(2021-2034)
11.5.2. Market Revenue Forecast by Application (2021-2034)
11.5.3. Market Revenue Forecast by End-user (2021-2034)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2021-2034)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2021-2034)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2021-2034)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2021-2034)
12.1. Zimmer Biomet
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin
12.1.4. Recent Developments and Strategies
12.2. Arthrex, Inc.
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin
12.2.4. Recent Developments and Strategies
12.3. Harvest Technologies Corporation
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin
12.3.4. Recent Developments and Strategies
12.4. Stryker Corporation
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin
12.4.4. Recent Developments and Strategies
12.5. DePuy Synthes, Inc.
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin
12.5.4. Recent Developments and Strategies
12.6. Cesca Therapeutics, Inc.
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin
12.6.4. Recent Developments and Strategies
12.7. AdiStem Ltd.
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin
12.7.4. Recent Developments and Strategies
12.8. Exactech Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin
12.8.4. Recent Developments and Strategies
12.9. ISTO Biologics
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin
12.9.4. Recent Developments and Strategies
12.10. Nuo Therapeutics
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin
12.10.4. Recent Developments and Strategies
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client